Mia's Feed
Medical News & Research

Hypothermia-Induced Temperature Changes Uncover New Insights into Glucose Metabolism and Metabolic Diseases

Hypothermia-Induced Temperature Changes Uncover New Insights into Glucose Metabolism and Metabolic Diseases

Share this article

New research reveals that lowering body temperature actively influences glucose metabolism and may provide innovative approaches for treating metabolic diseases like diabetes and obesity.

2 min read

Recent research has shed light on the intricate relationship between body temperature and glucose metabolism, particularly during states of hypothermia, such as hibernation. While it has long been observed that animals like hibernators lower their body temperature to conserve energy during periods of food scarcity, the exact causative link between temperature regulation and metabolic activity has remained elusive. Traditionally, scientists believed that metabolism generated heat, which then influenced body temperature. However, new studies using advanced mouse models have challenged this notion.

A team from the Exploratory Research Center on Life and Living Systems (ExCELLS) and the National Institute for Physiological Sciences (NIPS) employed a novel model called Q-neuron-induced hypothermia and hypometabolism (QIH). This model allows safe induction of hypothermia in mice, enabling researchers to investigate how lowered body temperature alone affects metabolic processes without confounding factors.

The findings revealed that reducing body temperature causes a significant decrease in glucose metabolism across various tissues, including brown adipose tissue, skeletal muscle, the heart, and the brain. Notably, mice in the hypothermic state exhibited elevated fasting glucose and insulin levels—key indicators of insulin resistance, a hallmark of type 2 diabetes. These high glucose and insulin levels normalized promptly after rewarming, demonstrating that body temperature itself actively regulates glucose metabolism rather than being merely a passive outcome.

This research indicates that body temperature is an active modulator of systemic metabolic health. It suggests that hypothermia can temporarily induce a diabetic-like state in healthy animals, which is reversible through rewarming. Such discoveries open promising avenues for non-pharmacological interventions targeting metabolic disorders like diabetes and obesity. Further investigations aim to uncover the cellular and molecular mechanisms underlying this temperature-metabolism link, paving the way for innovative temperature-based therapies to manage metabolic disease and systemic inflammation.

Source: https://medicalxpress.com/news/2025-07-hypothermia-glucose-metabolism-reveal-mechanisms.html

Stay Updated with Mia's Feed

Get the latest health & wellness insights delivered straight to your inbox.

How often would you like updates?

We respect your privacy. Unsubscribe at any time.

Related Articles

Emerging Evidence Supports Minimalist Technique in Transcatheter Aortic Valve Replacement

Latest research at ESC Congress 2025 confirms the safety and efficacy of a minimalist, sedation-free approach to transcatheter aortic valve implantation, offering benefits over traditional methods.

Innovative Topical Cream Targeting Dopamine Pathways to Prevent Parasitic Worm Infections

A groundbreaking study reveals that disrupting dopamine pathways in parasitic worms could prevent skin infections. UCLA researchers identify a potential target for innovative topical treatments against parasitic nematodes like Strongyloides stercoralis, offering hope for improved prevention in affected regions.

Innovative Therapy Targets Astrocytes to Enhance Immune Response Against Glioblastoma

A novel therapeutic approach aims to enhance immune responses against glioblastoma by targeting astrocytes that suppress T cell activity, potentially opening new avenues for treatment.

New Study Reveals Vepdegestrant Extends Survival in Patients with Advanced ER+ Breast Cancer Featuring ESR1 Mutations

A new clinical trial reveals that vepdegestrant significantly improves progression-free survival in patients with ER-positive, HER2-negative advanced breast cancer with ESR1 mutations. Learn about the latest advancements in targeted breast cancer therapy.